B cells are associated with survival and immunotherapy response in sarcoma-Reference-Cited by-同舟云学术

B cells are associated with survival and immunotherapy response in sarcoma

Published:2020-01-15 Issue:7791 Volume:577 Page:556-560
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Petitprez Florent,de Reyniès Aurélien,Keung Emily Z.,Chen Tom Wei-Wu,Sun Cheng-Ming,Calderaro Julien,Jeng Yung-Ming,Hsiao Li-Ping,Lacroix Laetitia,Bougoüin Antoine,Moreira Marco,Lacroix Guillaume,Natario Ivo,Adam Julien,Lucchesi Carlo,Laizet Yec′han,Toulmonde Maud,Burgess Melissa A.,Bolejack Vanessa,Reinke Denise,Wani Khalid M.,Wang Wei-Lien,Lazar Alexander J.,Roland Christina L.,Wargo Jennifer A.,Italiano Antoine,Sautès-Fridman Catherine,Tawbi Hussein A.,Fridman Wolf H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1906-8.pdf

Reference40 articles.

1. Helman, L. J. & Meltzer, P. Mechanisms of sarcoma development. Nat. Rev. Cancer 3, 685–694 (2003).

2. Fletcher, C., Bridge, J., Hogendoorn, P. & Mertens, F. WHO Classification of Tumours of Soft Tissue and Bone (World Health Organization, 2013).

3. D’Angelo, S. P. et al. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Lancet Oncol. 19, 416–426 (2018).

4. Tawbi, H. A. et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 18, 1493–1501 (2017).

5. Beck, A. H. et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 29, 845–854 (2010).

Cited by 1268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. scQA: A dual-perspective cell type identification model for single cell transcriptome data;Computational and Structural Biotechnology Journal;2024-12

2. Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans;Current Opinion in Immunology;2024-12

3. CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer;International Immunopharmacology;2024-11

4. Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies;Cancer Letters;2024-10

5. Application of spatial omics in gastric cancer;Pathology - Research and Practice;2024-10